CPT® Code 90470

Deleted

1. Indications

The H1N1 immunization administration is indicated for individuals who require protection against the H1N1 influenza virus. This includes, but is not limited to, the following:

• High-Risk Populations Individuals who are at a higher risk of developing severe complications from H1N1, such as young children, elderly individuals, pregnant women, and those with chronic health conditions.
• Seasonal Vaccination Routine immunization during flu season to prevent the spread of H1N1 influenza within the community.
• Public Health Initiatives Vaccination campaigns aimed at increasing immunity in the population to control outbreaks of H1N1.

2. Procedure

The procedure for administering the H1N1 immunization involves several key steps, which are outlined as follows:

• Step 1: Patient Assessment Prior to administration, the healthcare provider assesses the patient’s medical history and current health status to determine eligibility for the H1N1 vaccine. This may include reviewing any contraindications or previous adverse reactions to vaccines.
• Step 2: Vaccine Preparation The appropriate H1N1 vaccine is selected based on the patient’s age and health condition. The vaccine is prepared according to manufacturer guidelines, ensuring sterility and proper dosage.
• Step 3: Administration of the Vaccine The vaccine is administered either intramuscularly or intranasally, depending on the formulation used. For intramuscular administration, the injection is typically given in the deltoid muscle of the upper arm. For intranasal administration, the vaccine is sprayed into the nostrils as directed.
• Step 4: Counseling After the administration, the healthcare provider offers counseling to the patient, which may include information about potential side effects, the importance of the vaccine, and any follow-up care that may be necessary.
• Step 5: Documentation The administration of the vaccine is documented in the patient’s medical record, including the date, type of vaccine, route of administration, and any counseling provided.

3. Post-Procedure

Post-procedure care following the H1N1 immunization administration typically involves monitoring the patient for any immediate adverse reactions, which may include mild side effects such as soreness at the injection site, low-grade fever, or fatigue. Patients are advised to remain in the healthcare setting for a short period after administration to ensure their safety. Additionally, patients should be informed about the expected timeline for immunity development and advised to report any unusual symptoms or severe reactions that may occur after leaving the facility. Follow-up appointments may be scheduled as necessary to ensure continued health and vaccination compliance.